A drug with the SMILES Cc1ccc2[nH]c3nc(SCCN4CCOCC4)nnc3c2c1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 8.911%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1ccc2[nH]c3nc(SCCN4CCOCC4)nnc3c2c1
Cc1ccc2[nH]c3nc(SCCN4CCOCC4)nnc3c2c1
4-[2-[(8-methyl-5H-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]ethyl]morpholine